TITLE

…about living with MS for 40 years

AUTHOR(S)
Phipps, Tyra C.
PUB. DATE
December 2006
SOURCE
Inside MS;Dec2006/Jan2007, Vol. 24 Issue 6, p58
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this article, the author shares her experience in living with multiple sclerosis (MS). The author experienced the symptoms of MS since she was 11 years old, particularly while playing tennis. Her vision was getting impaired and her legs were getting weak. In her 40s, she returned to teaching. But her students kept evaluating her as an alcoholic. One student wrote that she was constantly holding onto the blackboard and it was clear that she had a hangover. Finally, she told everyone she had MS.
ACCESSION #
23493249

 

Related Articles

  • Depression and fatigue in relapsing - remitting MS: the role of symptomatic variability. Randolph, John J.; Arnett, Peter A. // Multiple Sclerosis (13524585);Apr2005, Vol. 11 Issue 2, p186 

    Depression and fatigue are common psychosocial sequelae of MS. An infrequently examined issue in the MS literature is the effect of MS-related symptom variability on incidence of depression and fatigue. The current study was designed to examine the relationship of variability in physical,...

  • an Overview of MS. Guarnaccia, Joseph B.; Booss, John // PN;Feb2005, Vol. 59 Issue 2, p32 

    Presents facts and information about multiple sclerosis. Clinical definition; People that are afflicted by multiple sclerosis and its genetic factors; Diagnosis and symptoms; Prospects for multiple sclerosis treatments. INSET: NEW EDITION OF MS WELLNESS GUIDE.

  • Management of Fatigue in Patients with Multiple Sclerosis. Zifko, Udo A. // Drugs;2004, Vol. 64 Issue 12, p1295 

    As long as no causal treatment is available for multiple sclerosis (MS), and as long as only some patients with MS respond to immunomodulators, symptomatic treatment is of paramount importance. Fatigue is the most common symptom of MS and is associated with a reduced quality of life. It is...

  • Multiple sclerosis TURNED ME INTO AN AUTHOR. Balt, Kathy // Woman's Day (Australia Edition);12/1/2003, Vol. 55 Issue 48, p106 

    Presents an article on battling with multiple sclerosis. Symptoms of multiple sclerosis; Determination in fighting the disease; Objective in writing a book on multiple sclerosis.

  • MS symptoms.  // Multiple Sclerosis (13524585);Sep2005 Supplement, Vol. 11, p34 

    Discusses abstracts of studies about symptoms of multiple sclerosis, published in the October 2005 issue of the periodical "Multiple Sclerosis". "Clinical Profile of Multiple Sclerosis Patients in Wisconsin, USA," by B. Khatri and colleagues; "The First Clinical Findings in Iranian MS Patients,"...

  • Insight into Multiple Sclerosis. Wehman-Tubbs, Kelli; Yale, Steven H.; Rolak, Loren A. // Clinical Medicine & Research;Feb2005, Vol. 3 Issue 1, p41 

    Presents information on multiple sclerosis. Knowledge of the pathogenesis of multiple sclerosis; Definition of the most common presentation for patients with multiple sclerosis; Tests available to assist in the diagnosis of multiple sclerosis.

  • The Lesions of Multiple Sclerosis. Paty, Donald W.; Arnold, Douglas L. // New England Journal of Medicine;1/17/2002, Vol. 346 Issue 3, p199 

    Editorial. Discusses multiple sclerosis (MS). Reference to reports by Chang and colleagues and by Brex et al in this issue; How the findings are important to an understanding of the remyelination of lesions of MS and imply that transplantation of oligodendrocyte precursor cells will probably not...

  • Defining the natural history of MS: the need for complete data and rigorous definitions. Confavreux, C. // Multiple Sclerosis (13524585);Apr2008, Vol. 14 Issue 3, p289 

    The article reports on the study regarding secondary progressive multiple sclerosis (SPMS) in British Columbia. It found that the median time from an exacerbating-remitting onset of MS to conversion to secondary progression could be estimated using the Kaplan-Meier technique. It also shows that...

  • American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study. Kim, E; Cameron, M; Lovera, J; Schaben, L; Bourdette, D; Whitham, R // Multiple Sclerosis Journal;Dec2011, Vol. 17 Issue 12, p1523 

    This study examined the safety and efficacy of an escalating dose (100?mg, 200?mg, 400?mg/day) of American ginseng over 6 weeks in a single-center, randomized, double-blind, placebo-controlled, crossover trial with 56 subjects with multiple sclerosis and fatigue. There were no serious adverse...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics